SEC Filings | Landos Biopharma

Filing date	Form	Description	View
05/24/23	4	Statement of changes in beneficial ownership of securities	0001209191-23-031943.pdf 0001209191-23-031943.rtf 0001209191-23-031943.xls View HTML
05/24/23	4	Statement of changes in beneficial ownership of securities	0001209191-23-031945.pdf 0001209191-23-031945.rtf 0001209191-23-031945.xls View HTML
05/24/23	4	Statement of changes in beneficial ownership of securities	0001209191-23-031947.pdf 0001209191-23-031947.rtf 0001209191-23-031947.xls View HTML
06/01/23	4	Statement of changes in beneficial ownership of securities	0001209191-23-033341.pdf 0001209191-23-033341.rtf 0001209191-23-033341.xls View HTML
02/04/21	424B4	Form of prospectus disclosing information facts events covered in both forms 424B1 424B3	0001193125-21-028952.pdf 7.5 MB 0001193125-21-028952.rtf 0001193125-21-028952.xls View HTML
02/14/22	5	Annual filing director officer or owner of more than ten percent.	0001843575-22-000001.pdf 0001843575-22-000001.rtf 0001843575-22-000001.xls View HTML
02/14/23	5	Annual filing director officer or owner of more than ten percent.	0001843575-23-000001.pdf 0001843575-23-000001.rtf 0001843575-23-000001.xls View HTML
02/01/21	8-A12B	Registration of certain classes of securities 12(b) of the Securities Exchange Act	0001193125-21-024167.pdf 161.7 KB 0001193125-21-024167.rtf 0001193125-21-024167.xls View HTML
02/08/21	8-K	Report of unscheduled material events or corporate event	0001193125-21-032333.pdf 149.5 KB 0001193125-21-032333.rtf 0001193125-21-032333.xls View HTML
04/13/21	8-K	Report of unscheduled material events or corporate event	0001193125-21-114057.pdf 183.4 KB 0001193125-21-114057.rtf 0001193125-21-114057.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML

Data provided by Kaleidoscope.